Data science in pharmaceutical R&D: the DISRUPT-DS industry roundtable

IF 122.7 1区医学 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Nature Reviews. Drug Discovery Pub Date : 2024-07-15 DOI:10.1038/d41573-024-00104-5

Najat S. Khan, Thomas Senderovitz, James Weatherall, Janice Branson, Benedikt Egersdoerfer, Eric Genevois-Marlin, Sai Jasti, Mustaqhusain Kazi, Ranjit Kumble, Patrick Loerch, Justine Rochon, Venkat Sethuraman, Matt Studney, Xiaoying Wu, Ryan Copping, Priya Chandran, Madura Jayatunga, Dhruv Jayanth, Christoph Meier

{"title":"Data science in pharmaceutical R&D: the DISRUPT-DS industry roundtable","authors":"Najat S. Khan, \n Thomas Senderovitz, \n James Weatherall, \n Janice Branson, \n Benedikt Egersdoerfer, \n Eric Genevois-Marlin, \n Sai Jasti, \n Mustaqhusain Kazi, \n Ranjit Kumble, \n Patrick Loerch, \n Justine Rochon, \n Venkat Sethuraman, \n Matt Studney, \n Xiaoying Wu, \n Ryan Copping, \n Priya Chandran, \n Madura Jayatunga, \n Dhruv Jayanth, \n Christoph Meier","doi":"10.1038/d41573-024-00104-5","DOIUrl":null,"url":null,"abstract":"The DISRUPT-DS roundtable, which brings together data science leaders from large pharmaceutical companies, aims to be a forum for sharing experiences and networking, for shaping industry-level topics and for amplifying the role of data science across pharmaceutical R&D. The DISRUPT-DS roundtable, which brings together data science leaders from large pharmaceutical companies, aims to be a forum for sharing experiences and networking, for shaping industry-level topics and for amplifying the role of data science across pharmaceutical R&D.","PeriodicalId":19068,"journal":{"name":"Nature Reviews. Drug Discovery","volume":"23 9","pages":"645-646"},"PeriodicalIF":122.7000,"publicationDate":"2024-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Reviews. Drug Discovery","FirstCategoryId":"3","ListUrlMain":"https://www.nature.com/articles/d41573-024-00104-5","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

The DISRUPT-DS roundtable, which brings together data science leaders from large pharmaceutical companies, aims to be a forum for sharing experiences and networking, for shaping industry-level topics and for amplifying the role of data science across pharmaceutical R&D. The DISRUPT-DS roundtable, which brings together data science leaders from large pharmaceutical companies, aims to be a forum for sharing experiences and networking, for shaping industry-level topics and for amplifying the role of data science across pharmaceutical R&D.

查看原文本刊更多论文

制药研发中的数据科学：DISRUPT-DS 行业圆桌会议

DISRUPT-DS 圆桌会议汇集了来自大型制药公司的数据科学领导者，旨在成为一个分享经验和建立联系的论坛，形成行业级的主题，并在整个制药研发过程中扩大数据科学的作用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature Reviews. Drug Discovery 医学-生物工程与应用微生物

CiteScore

137.40

自引率

0.30%

发文量

227

期刊介绍： Nature Reviews Drug Discovery is a monthly journal aimed at everyone working in the drug discovery and development arena. Each issue includes: Highest-quality reviews and perspectives covering a broad scope. News stories investigating the hottest topics in drug discovery. Timely summaries of key primary research papers. Concise updates on the latest advances in areas such as new drug approvals, patent law, and emerging industry trends and strategies.